Prevalence of liver tumours in HIV-1 tat-transgenic mice treated with urethane.
The human immunodeficiency virus type 1 (HIV-1) Tat protein stimulates cell proliferation, inhibits apoptosis, displays angiogenic functions and is believed to be involved in the pathogenesis of Kaposi's sarcoma (KS) and other tumours arising in AIDS patients. Tat-transgenic (TT) mice, which constitutively express Tat in all tissues and organs, may therefore be predisposed to tumorigenesis. To test this hypothesis, we treated TT mice with urethane, a general carcinogen inducing tumours of various organs. The results indicate that, after injection of urethane, the incidence of lung tumours and lymphomas is not significantly different in the TT and control (CC) mice, whereas liver preneoplastic lesions and tumours show a significantly greater incidence in TT than in CC mice. This remarkable carcinogenic effect of urethane for the liver may be due to a tat-induced predisposition, manifested as a liver cell dysplasia (LCD), spontaneously affecting most of the TT mice. LCD may exert a promoting effect by stimulating proliferation of cell clones initiated by the mutagenic effect of urethane. In addition, LCD, which is associated with aneuploidy and chromosome instability, may enhance the progression to malignancy of the preneoplastic lesions induced by urethane. Interestingly, a significantly greater incidence of vascular ectasias and haemangiomas was detected in the liver of urethane-treated TT mice, most likely due to the marked angiogenic properties of Tat. This study suggests a role for Tat in the promotion and progression of tumours initiated by exogenous and endogenous carcinogens in HIV-1-infected patients, thereby contributing to the tumorigenesis in the course of AIDS.
Altavilla
G
G
Institute of Pathologic Anatomy and Histology, University of Padova, I-35100 Padova, Italy.
Caputo
A
A
Trabanelli
C
C
Brocca Cofano
E
E
Sabbioni
S
S
Menegatti
M A
MA
Barbanti-Brodano
G
G
Corallini
A
A
D000818:Animals; D002273:Carcinogens / Q000633:toxicity*; D002455:Cell Division; D018076:DNA, Complementary / Q000032:analysis; D005260:Female; D015696:Gene Products, tat; D015658:HIV Infections; D015497:HIV-1; D006801:Humans; D007150:Immunohistochemistry; D008099:Liver / Q000737:chemistry; D008113:Liver Neoplasms / Q000139:chemically induced* / Q000473:pathology; D008175:Lung Neoplasms / Q000139:chemically induced; D008223:Lymphoma / Q000139:chemically induced; D008297:Male; D051379:Mice; D008822:Mice, Transgenic; D009693:Nucleic Acid Hybridization; D016133:Polymerase Chain Reaction / Q000379:methods; D014520:Urethane / Q000633:toxicity*; D054322:tat Gene Products, Human Immunodeficiency Virus
D002273:Carcinogens; D018076:DNA, Complementary; D015696:Gene Products, tat; D054322:tat Gene Products, Human Immunodeficiency Virus; D014520:Urethane